ESGCT x KACTUS 2025

By Hannah Flaherty

September 3, 2025

Menu

What is ESGCT?

The European Society of Gene & Cell Therapy is a professional society that supports basic and clinical research in gene therapy and cell therapy, fosters education, and promotes collaboration across academia, industry, and regulators in Europe. Its Annual Congress is the society’s flagship meeting, featuring keynotes, invited and selected talks, poster sessions, and an exhibition.

Event Overview

Venue: FIBES, Seville Exhibition and Conference Centre (Palacio de Exposiciones y Congresos), Av. Alcalde Luis Uruñuela, 1, 41020 Sevilla, Spain.

Dates: October 7th to 10th, 2025

Conference Day 1: Tuesday 7 October, 2025 14:00–21:00
Conference Day 2: Wednesday 8 October, 2025 08:30–19:30
Conference Day 3: Thursday 9 October, 2025 09:00–19:30
Conference Day 4: Friday 10 October, 2025 09:00–17:30

KACTUS Booth: #A34

Event Schedule

The 32nd ESGCT Annual Congress will run for four days, October 7 to 10, 2025, with keynotes, parallel sessions, posters, and networking designed to spark collaboration and share new findings in gene and cell therapy. For the most up-to-date daily schedule, including session times and talk details, please consult the live Full Programme on the ESGCT website or in the ESGCT app. For a high-level view, use the programme at a glance.

Day 1: Tuesday, October 7, 2025

Education and workshop registration at 08:30
Education Sessions 1a and 1b from 09:00 to 10:45
Education session coffee break from 10:45 to 11:15
Education Sessions 2a and 2b from 11:15 to 13:00
Clinical Trials and Commercialisation Workshop 1 from 09:30 to 11:30
Workshop coffee break from 11:30 to 11:45
Clinical Trials and Commercialisation Workshop 2 from 11:45 to 13:00
General registration from 12:00 to 14:00
Plenary Session 1: ESGCT 2025 Opening from 14:00 to 16:30
Coffee break from 16:30 to 17:00
Parallel Sessions 2a to 2d from 17:00 to 19:30
Welcome Reception from 19:30 to 21:00

Day 2: Wednesday, October 8, 2025

Registration from 08:00 to 08:30
Parallel Sessions 3a to 3d from 08:30 to 10:30
Coffee break from 10:30 to 11:00
Plenary Session 4 from 11:00 to 13:00
Lunch from 13:00 to 14:00
Lunchtime Symposia from 13:30 to 14:30
Poster Session from 14:00 to 15:30
Plenary Session 5 from 15:30 to 17:30
Coffee break from 17:30 to 18:00
Parallel Sessions 6a to 6d from 18:00 to 19:30
Speakers’ Dinner at 20:00

Day 3: Thursday, October 9, 2025

Registration from 08:00 to 08:30
Parallel Sessions 7a to 7d from 08:30 to 10:30
Coffee break from 10:30 to 11:00
Plenary Session 8: Presidential Symposium from 11:00 to 13:15
ESGCT AGM from 13:15 to 13:30
Lunch from 13:15 to 14:00
Lunchtime Symposia from 13:30 to 14:30
Poster Session from 14:00 to 15:30
Parallel Sessions 9a to 9d from 15:30 to 17:30
Coffee break from 17:30 to 18:00
Parallel Sessions 10a to 10d from 18:00 to 19:30
Molecular Mingle at 20:30

Day 4: Friday, October 10, 2025

Registration from 08:30 to 09:00
Parallel Sessions 11a to 11d from 09:00 to 10:30
Coffee break from 10:30 to 11:00
Parallel Sessions 12a to 12d from 11:00 to 13:00
Lunch from 13:00 to 14:30
EuroGCT Lunchtime Symposium from 13:30 to 14:30
Plenary Session 13: Closing from 14:30 to 17:00
Concluding remarks from 17:00 to 17:15

About KACTUS

KACTUS excels in crafting and producing an array of superior-grade, highly active recombinant proteins and enzymes, catering to diverse sectors like antibody drug discovery, immunotherapy, gene therapy, and mRNA therapeutics. Our expansive catalog, boasting over 3,000 recombinant proteins, encompasses a wide spectrum of targets, species, tags, and labels, each thoughtfully chosen to address the specific, unmet needs of scientists engaged in drug development. The hallmark of our product selection process is a rigorous emphasis on exceptional quality and a steadfast commitment to ensuring reliable supply, thereby upholding the highest standards of excellence and client satisfaction.